Market Overview

Morning Market Movers

Share:
Related OMED
10 Biotech Stocks With Catalysts Coming Soon
OncoMed Reports Presentation of Phase 1b Trial for Tarextumab in Small Cell Lung Cancer at ASCO
OncoMed Pharma completes enrollment in mid-stage terextumab study in pancreatic cancer (Seeking Alpha)
Related CELG
William Blair's Best Ideas In A Volatile Market
Jim Cramer Advises His Viewers On Wells Fargo, Receptos And Celgene
Meet The Manager Of A Top Performing Mutual Fund (Investor's Business Daily)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (CELG + CNAT)

Get Benzinga's Newsletters